Paris, France

Pierre Yves Renard



 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Pierre Yves Renard

Introduction

Pierre Yves Renard is a notable inventor based in Paris, France. He has made significant contributions to the field of neuroscience through his innovative research and development of new compounds. With a total of 2 patents to his name, Renard is recognized for his work in creating highly functionalizable acetylcholinesterase inhibitors.

Latest Patents

Renard's latest patents include the development of a 7,11-methanocycloocta [b] quinoline derivative as a highly functionalizable acetylcholinesterase inhibitor. This innovative compound is designed to treat neurological diseases, particularly those affecting acetylcholine levels, such as Alzheimer's disease. His work on new highly functionalizable Huprine derivatives of formula I further emphasizes his commitment to advancing medical treatments.

Career Highlights

Pierre Yves Renard is affiliated with the Université de Rouen, where he conducts his research. His academic background and dedication to innovation have positioned him as a key figure in the field of neuroscience. Renard's work not only contributes to scientific knowledge but also has the potential to impact the lives of individuals suffering from neurological disorders.

Collaborations

Some of his notable coworkers include Cyril Ronco and Ludovic Jean. Their collaborative efforts have likely enhanced the research and development process, leading to the successful creation of new compounds.

Conclusion

Pierre Yves Renard's contributions to the field of neuroscience through his patents and research are commendable. His innovative work in developing acetylcholinesterase inhibitors showcases his dedication to improving treatments for neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…